sema + cagrilintide blend for weight loss New Drug CagriSema Shows Impressive Results in Clinical Trials Cagrilintide 3mg, Semaglutide 3mg Blend

BHRC Featured in GQ Magazine In a March 2026 GQ feature titled Its About to Be Hot Peptide Summer, BHRC Chief Innovation Officer Sanjiv Lal was interviewed alongside leading physicians and healthcare executives about the future of peptide regulation in the United States

Adapted from " Progression of Parkinson's Disease in the Substantia Nigra by BioRender.com (2021)

These data demonstrate that stress induces phosphorylation of Jak-3 in the hippocampus, which is prevented by treatment with the Jak-3 inhibitor IV (Fig

While most organoid research has focused on hepatocyte functionality and maturation, these findings illustrate the versatility of iHLOs across a range of applications, depending on the selected timepoint